<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04449341</url>
  </required_header>
  <id_info>
    <org_study_id>921118</org_study_id>
    <nct_id>NCT04449341</nct_id>
  </id_info>
  <brief_title>Can Virtual Reality Reduce Pain and Anxiety During Blood Draw</brief_title>
  <official_title>Can Virtual Reality Reduce Patient's Pain, Improve Patient's Experience, and Reduce Procedure Related Anxiety With Venipuncture? A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>C.R.Darnall Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>C.R.Darnall Army Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adult patients aged 18-50 undergoing blood draw for routine lab evaluation will be randomized&#xD;
      to a control group or experimental group to assess if the use of virtual reality reduces&#xD;
      procedural pain (primary outcome) and procedural anxiety (secondary outcome) during&#xD;
      venipuncture.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized controlled trial comparing standard practice for conducting&#xD;
      venipuncture to standard practice with the addition of Virtual Reality using the Oculus Go&#xD;
      Head Mounted Display (HMD). The study will be performed on volunteers who are reporting to&#xD;
      the phlebotomy lab to have venipuncture for blood draws that were previously ordered by their&#xD;
      health care providers. Participants who were not already scheduled to undergo routine&#xD;
      venipuncture will not be included.&#xD;
&#xD;
      When approaching the ticket stand to draw a waiting number for the lab, prospective&#xD;
      participants will be asked by an assistant investigator located near the kiosk if they are&#xD;
      interested in participating in the study. If the participants express interest, they will be&#xD;
      directed to the screening station. The screening station will be set up in a private room&#xD;
      near the lab waiting area, and participants will be screened for eligibility and educated on&#xD;
      the benefits and risks of the study. They will also provide informed consent if they decide&#xD;
      to participate.&#xD;
&#xD;
      All participants will be asked to fill out a self-reported data questionnaire in addition to&#xD;
      the informed consent document to assess for inclusion and exclusion criteria discussed later&#xD;
      in this protocol. This questionnaire will assess the participant's expected level of anxiety&#xD;
      prior to the procedure and expected level of pain associated with the procedure by utilizing&#xD;
      a visual analog scale (VAS). The VAS will be on a 100 millimeter line.&#xD;
&#xD;
      Once approved for participation in the study all participants will undergo a brief&#xD;
      instructional class on how to operate the HMD and will be allowed sufficient time to become&#xD;
      comfortable with its use. The investigators expect approximately 5-10 minutes to be required&#xD;
      for this portion of the study. Once familiar with the use of the virtual reality headset,&#xD;
      participants will be asked to randomly draw an envelope from a container. This envelope will&#xD;
      contain a block and sequence number. The block and sequence number will be the subject&#xD;
      identification and will correspond to a predetermined number set on a separate document that&#xD;
      will determine if the participant will use the HMD during venipuncture or not. The screener&#xD;
      will not have immediate access to the list showing which group the participant will be&#xD;
      assigned to. One member of the study team will be present in the lab room to ensure the&#xD;
      participant uses the virtual reality headset (or not) according to what is randomly drawn.&#xD;
      This member of the research team will have the list showing whether or not the participant is&#xD;
      assigned to the control arm or the experimental arm. The participants will then proceed to&#xD;
      the specimen room to undergo venipuncture.&#xD;
&#xD;
      Venipuncture for both groups will be occur in the non-dominant arm. The reasoning for this is&#xD;
      that the Oculus Go requires one free hand to use a controller. This will ensure that the&#xD;
      individuals participating are able to effectively use the device. Those unable to undergo&#xD;
      venipuncture in the nondominant arm will undergo venipuncture in the dominant arm instead and&#xD;
      will use the Oculus Go dominant arm will undergo venipuncture in the dominant arm instead and&#xD;
      will use the Oculus Go controller with their non-dominant hand.&#xD;
&#xD;
      Those utilizing the Oculus Go HMD will be interacting with the virtual reality game Ocean&#xD;
      Rift. They will utilize a single controller to explore an underwater safari park. Ocean Rift&#xD;
      has multiple environments to choose from, including coral reefs, ship wrecks, lagoons, the&#xD;
      arctic, and prehistoric seas. Participants may interact with and and learn about different&#xD;
      creatures to include dolphins, turtles, orcas, ray, whales, sea lions, manatees, and&#xD;
      dinosaurs. During the game users may travel where they please and interact with what they&#xD;
      choose. The virtual reality device is equipped with head-tracking software that allows the&#xD;
      user to choose direction by looking around. The entire interior and exterior of the headset&#xD;
      will be cleaned with alcohol-based wipes after each use. Alcohol will be used since it is&#xD;
      generally well-tolerated on human skin, and since it evaporates quickly. The headset will be&#xD;
      dried in the open air for a minimum of two minutes between each subject's use.&#xD;
&#xD;
      Those not using the virtual reality will still wear a headset that will simply be turned off.&#xD;
      This is to ensure that any significant change noted with the virtual reality is due to the&#xD;
      use of virtual reality itself, and not simply due to &quot;blindfolding&quot; the patient during the&#xD;
      procedure.&#xD;
&#xD;
      As some patients experiencing anxiety may be tempted to move during the procedure, lab&#xD;
      personnel will instruct participants to remain still during venipuncture. Participants will&#xD;
      be advised that they may take breaks as needed if anxiety becomes overwhelming.&#xD;
&#xD;
      After undergoing the procedure, each participant will be asked to fill out the postprocedure&#xD;
      questionnaire and return it to the study team member present in the lab room, who will clean&#xD;
      the headset as the participant completes the questionnaire. This questionnaire assesses the&#xD;
      patient's pain intensity and level of anxiety with the VAS similar to the VAS assessing pain,&#xD;
      as well as the patient's satisfaction with the visit which will be measured utilizing a&#xD;
      Likert scale for individual questions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 10, 2020</start_date>
  <completion_date type="Actual">July 9, 2020</completion_date>
  <primary_completion_date type="Actual">July 9, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural Pain</measure>
    <time_frame>2 months</time_frame>
    <description>Determine if use of Oculus Go headset reduces procedural pain perception utilizing the visual analog scale, which measures pain on a linear scale from 0 to 100 millimeters, with 0 being no pain and 100 being maximum pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural Anxiety</measure>
    <time_frame>2 months</time_frame>
    <description>Determine if use of Oculus Go headset reduces procedural anxiety utilizing the visual analog scale, which measures anxiety on a linear scale from 0 to 100 millimeters, with 0 being no anxiety and 100 being maximum anxiety</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Procedural Anxiety</condition>
  <condition>Procedural Pain</condition>
  <arm_group>
    <arm_group_label>Standard care venipuncture with additional of virtual reality</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing blood draw while interacting with VR application Ocean Rift while wearing Oculus Go headset</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care venipuncture without addition of virtual reality</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients undergoing blood draw while wearing Oculus Go headset that is turned off</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oculus Go headset with Ocean Rift application</intervention_name>
    <description>Information already included in arm description</description>
    <arm_group_label>Standard care venipuncture with additional of virtual reality</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults aged 18-50&#xD;
&#xD;
          -  Currently scheduled to undergo venipuncture&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Less than 18 years old or greater than 50 years old&#xD;
&#xD;
          -  History of motion sickness (nausea or vertigo)&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Reported history of blood borne disease (no request will be made for which disease&#xD;
             participant has)&#xD;
&#xD;
          -  Use of pain medication(s) on day of study&#xD;
&#xD;
          -  Current use of medical devices, including hearing aids, pacemakers, implanted cardiac&#xD;
             defibrillators&#xD;
&#xD;
          -  Currently experiencing headache/migraine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew J Perdue, PA</last_name>
    <role>Principal Investigator</role>
    <affiliation>C.R.Darnall Army Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Carl R Darnall Army Medical Center</name>
      <address>
        <city>Fort Hood</city>
        <state>Texas</state>
        <zip>76544</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://download.militaryonesource.mil/12038/MOS/Reports/2018-demographics-report.pdf</url>
    <description>2018 Demographics Report: Profile of the Military Community</description>
  </link>
  <reference>
    <citation>Atzori B, Hoffman HG, Vagnoli L, Patterson DR, Alhalabi W, Messeri A, Lauro Grotto R. Virtual Reality Analgesia During Venipuncture in Pediatric Patients With Onco-Hematological Diseases. Front Psychol. 2018 Dec 20;9:2508. doi: 10.3389/fpsyg.2018.02508. eCollection 2018.</citation>
    <PMID>30618938</PMID>
  </reference>
  <reference>
    <citation>Cassidy KL, Reid GJ, McGrath PJ, Finley GA, Smith DJ, Morley C, Szudek EA, Morton B. Watch needle, watch TV: Audiovisual distraction in preschool immunization. Pain Med. 2002 Jun;3(2):108-18.</citation>
    <PMID>15102157</PMID>
  </reference>
  <reference>
    <citation>Lee JS, Hobden E, Stiell IG, Wells GA. Clinically important change in the visual analog scale after adequate pain control. Acad Emerg Med. 2003 Oct;10(10):1128-30.</citation>
    <PMID>14525749</PMID>
  </reference>
  <reference>
    <citation>Dahlquist LM, Weiss KE, Law EF, Sil S, Herbert LJ, Horn SB, Wohlheiter K, Ackerman CS. Effects of videogame distraction and a virtual reality type head-mounted display helmet on cold pressor pain in young elementary school-aged children. J Pediatr Psychol. 2010 Jul;35(6):617-25. doi: 10.1093/jpepsy/jsp082. Epub 2009 Sep 28.</citation>
    <PMID>19786489</PMID>
  </reference>
  <reference>
    <citation>Garrett B, Taverner T, Masinde W, Gromala D, Shaw C, Negraeff M. A rapid evidence assessment of immersive virtual reality as an adjunct therapy in acute pain management in clinical practice. Clin J Pain. 2014 Dec;30(12):1089-98. doi: 10.1097/AJP.0000000000000064. Review.</citation>
    <PMID>24535053</PMID>
  </reference>
  <reference>
    <citation>Gold JI, Kim SH, Kant AJ, Joseph MH, Rizzo AS. Effectiveness of virtual reality for pediatric pain distraction during i.v. placement. Cyberpsychol Behav. 2006 Apr;9(2):207-12.</citation>
    <PMID>16640481</PMID>
  </reference>
  <reference>
    <citation>Gold JI, Belmont KA, Thomas DA. The neurobiology of virtual reality pain attenuation. Cyberpsychol Behav. 2007 Aug;10(4):536-44.</citation>
    <PMID>17711362</PMID>
  </reference>
  <reference>
    <citation>Hoffman HG, Patterson DR, Carrougher GJ, Sharar SR. Effectiveness of virtual reality-based pain control with multiple treatments. Clin J Pain. 2001 Sep;17(3):229-35.</citation>
    <PMID>11587113</PMID>
  </reference>
  <reference>
    <citation>Hoffman HG, Sharar SR, Coda B, Everett JJ, Ciol M, Richards T, Patterson DR. Manipulating presence influences the magnitude of virtual reality analgesia. Pain. 2004 Sep;111(1-2):162-8.</citation>
    <PMID>15327820</PMID>
  </reference>
  <reference>
    <citation>Li A, Montaño Z, Chen VJ, Gold JI. Virtual reality and pain management: current trends and future directions. Pain Manag. 2011 Mar;1(2):147-157.</citation>
    <PMID>21779307</PMID>
  </reference>
  <reference>
    <citation>Malloy KM, Milling LS. The effectiveness of virtual reality distraction for pain reduction: a systematic review. Clin Psychol Rev. 2010 Dec;30(8):1011-8. doi: 10.1016/j.cpr.2010.07.001. Epub 2010 Jul 13. Review.</citation>
    <PMID>20691523</PMID>
  </reference>
  <reference>
    <citation>Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001 Dec;38(6):633-8.</citation>
    <PMID>11719741</PMID>
  </reference>
  <reference>
    <citation>Moore B, Stocks C, Owens P. Trends in Emergency Department Visits, 2006-2014. Healthcare Cost and Utilization Project (HCUP) Statistical Brief #227. 2017</citation>
  </reference>
  <reference>
    <citation>Wiederhold BK, Gao K, Kong L, Wiederhold MD. Mobile devices as adjunctive pain management tools. Cyberpsychol Behav Soc Netw. 2014 Jun;17(6):385-9. doi: 10.1089/cyber.2014.0202.</citation>
    <PMID>24892202</PMID>
  </reference>
  <reference>
    <citation>Özalp Gerçeker G, Ayar D, Özdemir EZ, Bektaş M. Effects of virtual reality on pain, fear and anxiety during blood draw in children aged 5-12 years old: A randomised controlled study. J Clin Nurs. 2020 Apr;29(7-8):1151-1161. doi: 10.1111/jocn.15173. Epub 2020 Jan 22.</citation>
    <PMID>31889358</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 22, 2020</study_first_submitted>
  <study_first_submitted_qc>June 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2020</study_first_posted>
  <results_first_submitted>May 16, 2021</results_first_submitted>
  <results_first_submitted_qc>May 16, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 11, 2021</results_first_posted>
  <last_update_submitted>July 10, 2021</last_update_submitted>
  <last_update_submitted_qc>July 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>C.R.Darnall Army Medical Center</investigator_affiliation>
    <investigator_full_name>Matthew J. Perdue, DSc, PA-C</investigator_full_name>
    <investigator_title>Fellow, US Army-Baylor DSc Emergency Medicine PA Studies, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>virtual reality</keyword>
  <keyword>venipuncture</keyword>
  <keyword>blood draw</keyword>
  <keyword>Oculus Go</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Procedural</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 21, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT04449341/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Virtual Reality</title>
          <description>Patients undergoing blood draw while interacting with VR application Ocean Rift while wearing Oculus Go headset&#xD;
Oculus Go headset with Ocean Rift application: Information already included in arm description</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Patients undergoing blood draw while wearing Oculus Go headset that is turned off</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Care Venipuncture With Additional of Virtual Reality</title>
          <description>Patients undergoing blood draw while interacting with VR application Ocean Rift while wearing Oculus Go headset&#xD;
Oculus Go headset with Ocean Rift application: Information already included in arm description</description>
        </group>
        <group group_id="B2">
          <title>Standard Care Venipuncture Without Addition of Virtual Reality</title>
          <description>Patients undergoing blood draw while wearing Oculus Go headset that is turned off</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="28"/>
            <count group_id="B3" value="58"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                    <count group_id="B2" value="28"/>
                    <count group_id="B3" value="58"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Unknown</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                    <count group_id="B2" value="28"/>
                    <count group_id="B3" value="58"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Procedural Pain</title>
        <description>Determine if use of Oculus Go headset reduces procedural pain perception utilizing the visual analog scale, which measures pain on a linear scale from 0 to 100 millimeters, with 0 being no pain and 100 being maximum pain</description>
        <time_frame>2 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care Venipuncture With Additional of Virtual Reality</title>
            <description>Patients undergoing blood draw while interacting with VR application Ocean Rift while wearing Oculus Go headset&#xD;
Oculus Go headset with Ocean Rift application: Information already included in arm description</description>
          </group>
          <group group_id="O2">
            <title>Standard Care Venipuncture Without Addition of Virtual Reality</title>
            <description>Patients undergoing blood draw while wearing Oculus Go headset that is turned off</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Pain</title>
          <description>Determine if use of Oculus Go headset reduces procedural pain perception utilizing the visual analog scale, which measures pain on a linear scale from 0 to 100 millimeters, with 0 being no pain and 100 being maximum pain</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.50" lower_limit="0.25" upper_limit="30.75"/>
                    <measurement group_id="O2" value="5.00" lower_limit="1.00" upper_limit="24.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Anxiety</title>
        <description>Determine if use of Oculus Go headset reduces procedural anxiety utilizing the visual analog scale, which measures anxiety on a linear scale from 0 to 100 millimeters, with 0 being no anxiety and 100 being maximum anxiety</description>
        <time_frame>2 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care Venipuncture With Additional of Virtual Reality</title>
            <description>Patients undergoing blood draw while interacting with VR application Ocean Rift while wearing Oculus Go headset&#xD;
Oculus Go headset with Ocean Rift application: Information already included in arm description</description>
          </group>
          <group group_id="O2">
            <title>Standard Care Venipuncture Without Addition of Virtual Reality</title>
            <description>Patients undergoing blood draw while wearing Oculus Go headset that is turned off</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Anxiety</title>
          <description>Determine if use of Oculus Go headset reduces procedural anxiety utilizing the visual analog scale, which measures anxiety on a linear scale from 0 to 100 millimeters, with 0 being no anxiety and 100 being maximum anxiety</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="1.00" upper_limit="24.25"/>
                    <measurement group_id="O2" value="6.5" lower_limit=".25" upper_limit="30.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard Care Venipuncture With Additional of Virtual Reality</title>
          <description>Patients undergoing blood draw while interacting with VR application Ocean Rift while wearing Oculus Go headset&#xD;
Oculus Go headset with Ocean Rift application: Information already included in arm description</description>
        </group>
        <group group_id="E2">
          <title>Standard Care Venipuncture Without Addition of Virtual Reality</title>
          <description>Patients undergoing blood draw while wearing Oculus Go headset that is turned off</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Matthew Perdue</name_or_title>
      <organization>Carl R Darnall Army Medical Center</organization>
      <phone>(254) 553-4653</phone>
      <email>matthewperdue94@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

